Aptevo Therapeutics Inc (APVO) Company Profile & Statistics

Aptevo Therapeutics Inc
APVO
(Nasdaq - US)
N/A
1.08
-0.03 (-2.70%)
in:usd•As of: May 07, 2024 11:14 UTC -4
Open
1.10
High
1.10
Low
1.05

About Aptevo Therapeutics Inc

CEO

Marvin L. White

Headquarters

2401 4th avenue,suite 1050

seattle, wa 98121, united states

Auditor

Moss Adams LLP

Employees

Share Holders

111

Website

http://www.aptevotherapeutics.com

Industry

biotechnology

Sector

health technology

Company Overview

Aptevo Therapeutics Inc. is a biotechnology company which focused on developing oncology and hematology therapeutics. The company's platform consists of ADAPTIR(TM). Its product pipeline includes WinRho (R) SDF, HepaGam B (R), VARIZIG(R) and IXINITY (R) which are in pre-clinical stage. Aptevo Therapeutics Inc. is based in Seattle, Washington.

Aptevo Therapeutics Inc Statistics

Valuation Measures

Market Capitalization ²	464.40K
Enterprise Value	-16.44M
Enterprise Value/EBITDA (ttm)	0.58
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	0.03
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-112.27%
Return on Invested Capital (ttm)	-134.77%
Return on Assets (ttm)	-64.39%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-28.31M
Net Income Avi to Common (ttm)	-17.41M
Diluted EPS (ttm)	N/A

Share Statistics

Beta (5Y Monthly)	5.13
52-Week Change	-98.55%
S&P500 52-Week Change	28.11%
S&P500 Member	No
Stock Optionable	No
Total Shares Outstanding ¹	532.82K
Dividend Yield	0.00%
Float ⁴	427.00K
% Held by Insiders	0.31%
% Held by Institutions	8.06%

Balance Sheet

Total Cash (mrq)	16.90M
Total Cash Per Share (mrq)	31.73
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	2.64%
Quick Ratio (mrq)	2.64%
Book Value Per Share (mrq)	27.65

Cash Flow

Operating Cash Flow Per Share (ytd)	-42.23
Free Cash Flow (ytd)	-11.73M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Aptevo Therapeutics Inc

Trade With A Regulated Broker